Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004959712 | SCV005469244 | uncertain significance | Inborn genetic diseases | 2024-08-01 | criteria provided, single submitter | clinical testing | The c.6118G>A (p.D2040N) alteration is located in exon 40 (coding exon 40) of the PIEZO2 gene. This alteration results from a G to A substitution at nucleotide position 6118, causing the aspartic acid (D) at amino acid position 2040 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |